. . . . . . . . . . . . . . . . . . . "14 hours"@en . . . . . "* 17 to 23 L"@en . . . . "Methazolamid"@en . . . . . . . . . . . . . "For treatment of chronic open-angle glaucoma and acute angle-closure glaucoma"@en . . . "Humans and other mammals"@en . "approved"@en . . . . "A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma. [PubChem]"@en . . . . . . . . . . . . "M\u00E9thazolamide"@en . . . . "# Iyer GR, Bellantone RA, Taft DR: In vitro characterization of the erythrocyte distribution of methazolamide: a model of erythrocyte transport and binding kinetics. J Pharmacokinet Biopharm. 1999 Feb;27(1):45-66. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/10533697 # Shirato S, Kagaya F, Suzuki Y, Joukou S: Stevens-Johnson syndrome induced by methazolamide treatment. Arch Ophthalmol. 1997 Apr;115(4):550-3. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/9109770 # Skorobohach BJ, Ward DA, Hendrix DV: Effects of oral administration of methazolamide on intraocular pressure and aqueous humor flow rate in clinically normal dogs. Am J Vet Res. 2003 Feb;64(2):183-7. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/12602587"@en . . "Methazolamide"@en . "SID26747005"@en . "554-57-4"@en . "Metazolamida"@en . "55%"@en . . "Methazolamidum"@en . . . . . . . . "Methazolamide is well absorbed from the gastrointestinal tract."@en . . . "Methazolamide is a potent inhibitor of carbonic anhydrase. Inhibition of carbonic anhydrase in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport."@en . "Electrolyte imbalance, development of an acidotic state, and central nervous system effects might be expected to occur in the case of an overdose."@en . . . "Take with food, more than 6 hours before bedtime increase liquid intake."@en . . .